Order Article Reprints

Talaat KR, Porter CK, Chakraborty S, Feijoo BL, Brubaker J, Adjoodani BM, DeNearing B, Prouty MG, Poole ST, Bourgeois AL, et al. Validation of a Human Challenge Model Using an LT-Expressing Enterotoxigenic E. coli Strain (LSN03-016011) and Characterization of Potential Amelioration of Disease by an Investigational Oral Vaccine Candidate (VLA1701). Microorganisms. 2024; 12(4):727. https://doi.org/10.3390/microorganisms12040727

Talaat, Kawsar R., Chad K. Porter, Subhra Chakraborty, Brittany L. Feijoo, Jessica Brubaker, Brittany M. Adjoodani, Barbara DeNearing, Michael G. Prouty, Steven T. Poole, A. Louis Bourgeois, and et al. 2024. "Validation of a Human Challenge Model Using an LT-Expressing Enterotoxigenic E. coli Strain (LSN03-016011) and Characterization of Potential Amelioration of Disease by an Investigational Oral Vaccine Candidate (VLA1701)" Microorganisms 12, no. 4: 727. https://doi.org/10.3390/microorganisms12040727

Talaat, K. R., Porter, C. K., Chakraborty, S., Feijoo, B. L., Brubaker, J., Adjoodani, B. M., DeNearing, B., Prouty, M. G., Poole, S. T., Bourgeois, A. L., Billingsley, M., Sack, D. A., Eder-Lingelbach, S., & Taucher, C. (2024). Validation of a Human Challenge Model Using an LT-Expressing Enterotoxigenic E. coli Strain (LSN03-016011) and Characterization of Potential Amelioration of Disease by an Investigational Oral Vaccine Candidate (VLA1701). Microorganisms, 12(4), 727. https://doi.org/10.3390/microorganisms12040727